Cat.#: ACPP-1207
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1254 | Luteinizing Hormone Blocking Peptide (AC1254) | 250 µg | inquiry |
| ACPP-1599 | Human CHGB Protein (AC1599) | 2 µg | inquiry |
| ACPP-1732 | Human CHRNA6 Protein (AC1732) | 5 µg | inquiry |
| ACPP-1846 | Human FGF 9 Protein (AC1846) | 5 µg | inquiry |
| ACPP-1359 | iNOS Blocking Peptide (AC1359) | 250 µg | inquiry |
| ACPP-1575 | Human HMOX1 Protein (AC1575) | 10 µg | inquiry |
| ACPP-1741 | Human NDRG1 Protein (AC1741) | 10 µg | inquiry |
| ACPP-1206 | ELOVL4 Blocking Peptide (AC1206) | 250 µg | inquiry |
| ACPP-1742 | Human PRND Protein (AC1742) | 2 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.